rs369497122
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_StrongBP6BP7BS1
The NM_015627.3(LDLRAP1):c.396C>T(p.Ile132Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000561 in 1,614,174 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015627.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDLRAP1 | ENST00000374338.5 | c.396C>T | p.Ile132Ile | synonymous_variant | Exon 4 of 9 | 1 | NM_015627.3 | ENSP00000363458.4 | ||
LDLRAP1 | ENST00000462394.1 | n.144C>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
LDLRAP1 | ENST00000488127.1 | n.866C>T | non_coding_transcript_exon_variant | Exon 3 of 7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000486 AC: 74AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000481 AC: 121AN: 251420Hom.: 1 AF XY: 0.000449 AC XY: 61AN XY: 135886
GnomAD4 exome AF: 0.000569 AC: 832AN: 1461874Hom.: 1 Cov.: 32 AF XY: 0.000561 AC XY: 408AN XY: 727246
GnomAD4 genome AF: 0.000486 AC: 74AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000416 AC XY: 31AN XY: 74470
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 4 Uncertain:1Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
This is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). -
- -
not provided Benign:2
- -
- -
not specified Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Familial hypercholesterolemia Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at